Our Brands

Equine		Canine
Unique joint prescription backed by science, proven over time, and trusted by veterinarians, Adequan^® I.M. (polysulfated glycosaminoglycan) treats degenerative joint disease to help horses enjoy greater mobility for a lifetime.^1,2,3		The only polysulfated glycosaminoglycan (PSGAG) that has never been duplicated. Adequan^® Canine is a disease-modifying osteoarthritis (OA) drug that proactively treats the disease and not just the clinical signs of OA.⁴

LEARN MORE		LEARN MORE

Equine

Two unique joint prescriptions backed by science, proven over time, and trusted by veterinarians. Adequan^® i.m. (polysulfated glycosaminoglycan) treats degenerative joint disease to help horses enjoy greater mobility for a lifetime.^1,2,3

LEARN MORE

Canine

The approved formula that’s never been duplicated. It proactively treats the disease and not just the signs of canine osteoarthritis.⁵

LEARN MORE

Adequan^® I.M. Brand of Polysulfated Glycosaminoglycan (PSGAG)

INDICATIONS
Adequan^® I.M. is recommended for the treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness in horses.

IMPORTANT SAFETY INFORMATION
Adequan^® I.M. is for veterinary use only. The prescribing information contains complete use information which includes dosing, contraindications, warnings and cautions. Always read, understand and follow label and use directions. PLEASE CONSULT Full Prescribing Information.

Adequan^® Canine Brand of Polysulfated Glycosaminoglycan (PSGAG)

INDICATIONS
Adequan^® Canine is recommended for the treatment of non-infectious degenerative and/or traumatic arthritis and associated lameness of canine synovial joints.

IMPORTANT SAFETY INFORMATION
Adequan^® Canine is for veterinary use only. The prescribing information contains complete use information which includes dosing, contraindications, warnings and cautions. Always read, understand and follow label and use directions. PLEASE CONSULT Full Prescribing Information.

1. Adequan^® I.M. (polysulfated glycosaminoglycan sterile injection 100 mg/mL), Package Insert IN99501C. American Regent, Inc.
2. Kim DY, Taylor HW, Moore RM, Paulsen DB, Cho DY. Articular chondrocyte apoptosis in equine osteoarthritis. The Veterinary Journal 2003; 166: 52-57.
3. McIlwraith CW, Frisbie DD, Kawcak CE, van Weeren PR. Joint Disease in the Horse. St. Louis, MO: Elsevier, 2016; 33-48.
4. Adequan^® Canine (polysulfated glycosaminoglycan sterile injection 100 mg/mL), Package Insert IN00502C. American Regent, Inc.

Report an Adverse Event or Product Quality Complaint